| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine (D.E.L., L.N.) and Clinical Chemistry (K.P.), Kuopio University Hospital, Kuopio, Finland; Research Institute of Public Health (K.N., T.-P.T., V.-P.V., J.T.S.), Departments of Physiology (D.E.L.) and Public Health and General Practice (J.T.S.), University of Kuopio, FIN-70211 Kuopio, Finland; and Oy Jurilab Ltd. (J.T.S.), FIN-70211 Kuopio, Finland
Address all correspondence and requests for reprints to: Kristiina Nyyssönen, Ph.D., Research Institute of Public Health, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: Kristiina. Nyyssonen{at}uku.fi.
In men, hypoandrogenism is associated with features of the metabolic syndrome. It is not known whether men with the metabolic syndrome are at a higher risk of developing hypogonadism. We therefore assessed whether the metabolic syndrome predicts development of hypogonadism 11 yr later in 651 middle-aged Finnish men participating in a population-based cohort study. Men with the metabolic syndrome at baseline as defined by the World Health Organization (n = 114, 20%) had a 2.6-fold increased risk of developing hypogonadism as defined by total testosterone levels less than 11 nmol/liter at the 11-yr follow-up independent of age, smoking, and other potential confounders. Further adjustment for body mass index (OR, 2.0; 95% CI, 1.13.8) or baseline total testosterone levels (OR, 1.9; 95% CI, 1.03.4) attenuated the association. The association of the metabolic syndrome with hypogonadism as defined by calculated free testosterone levels less than 225 pmol/liter was similar, but weaker. The adjusted decrease in testosterone concentrations during the 11-yr follow-up was also greater in men with than without the metabolic syndrome. Smokers had a nonsignificantly lower risk of developing hypogonadism during follow-up, whereas a decrease in smoking increased the risk of hypogonadism. The metabolic syndrome predisposes to development of hypogonadism in middle-aged men. Prevention of abdominal obesity and the accompanying metabolic syndrome in middle age may decrease the risk of hypogonadism in men, especially in those who quit smoking.
This article has been cited by other articles:
![]() |
A. D. Coviello, S. Sam, R. S. Legro, and A. Dunaif High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4361 - 4366. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Guay The Emerging Link Between Hypogonadism and Metabolic Syndrome J Androl, July 1, 2009; 30(4): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Traish, A. Guay, R. Feeley, and F. Saad The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction J Androl, January 1, 2009; 30(1): 10 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bondy Endogenous sex hormones and type 2 diabetes risk. JAMA, July 12, 2006; 296(2): 169 - 169. [Full Text] [PDF] |
||||
![]() |
E. Orwoll, L. C. Lambert, L. M. Marshall, K. Phipps, J. Blank, E. Barrett-Connor, J. Cauley, K. Ensrud, S. Cummings, and for the Osteoporotic Fractures in Men Study Group Testosterone and Estradiol among Older Men J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1336 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kurl, J. A. Laukkanen, L. Niskanen, D. Laaksonen, J. Sivenius, K. Nyyssonen, and J. T. Salonen Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men Stroke, March 1, 2006; 37(3): 806 - 811. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |